Minimal-Dose Resistance Training for Improving sIgA and Cortisol

Minimal-Dose Resistance Training for Improving sIgA and Cortisol Among Young, Health and Sedentary People

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05221996

Acronym

sIgA

Enrollment

Registered

2022-02-03

Start date

2022-02-01

Completion date

2022-03-24

Last updated

2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune System, Resistance Training

Keywords

resistance training, immune system, cortisol

Brief summary

Whereas the role of endurance training on immune function has been widely studied, little is known about the role of resistance training (RT). In this cross-over randomized controlled study, it will be analysed the effects of three RT protocols which only differs in volume in improving secretory immunoglobulin A (sIgA) and cortisol in saliva among young, health and sedentary people

Interventions

BEHAVIORALResistance training

Resistance circuit training

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

SCREENING

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-30 years * Sedentary

Exclusion criteria

* to have had COVID-19 during the last 3 months * to have been vaccinated against COVID-19 during the last 3 months * physical limitations or health problems

Design outcomes

Primary

Measure	Time frame	Description
Concentration of secretory immunoglobulin A (sIgA)	2 weeks	Secretory Immunoglobulin A in saliva

Secondary

Measure	Time frame	Description
Concentration of salivary cortisol (Scortisol)	2 weeks	Cortisol in saliva

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026